table of content
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Molecular Diagnostics Overall Market Size
2.1 Global Prostate Cancer Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Prostate Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Prostate Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Prostate Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Prostate Cancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Prostate Cancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Prostate Cancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
7 Prostate Cancer Molecular Diagnostics Companies Profiles
7.1 Qiagen
7.1.1 Qiagen Company Summary
7.1.2 Qiagen Business Overview
7.1.3 Qiagen Prostate Cancer Molecular Diagnostics Major Product Offerings
7.1.4 Qiagen Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Qiagen Key News & Latest Developments
7.2 Foundationmedicine
7.2.1 Foundationmedicine Company Summary
7.2.2 Foundationmedicine Business Overview
7.2.3 Foundationmedicine Prostate Cancer Molecular Diagnostics Major Product Offerings
7.2.4 Foundationmedicine Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Foundationmedicine Key News & Latest Developments
7.3 Genetech
7.3.1 Genetech Company Summary
7.3.2 Genetech Business Overview
7.3.3 Genetech Prostate Cancer Molecular Diagnostics Major Product Offerings
7.3.4 Genetech Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Genetech Key News & Latest Developments
7.4 Gpmedical
7.4.1 Gpmedical Company Summary
7.4.2 Gpmedical Business Overview
7.4.3 Gpmedical Prostate Cancer Molecular Diagnostics Major Product Offerings
7.4.4 Gpmedical Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Gpmedical Key News & Latest Developments
7.5 Premed
7.5.1 Premed Company Summary
7.5.2 Premed Business Overview
7.5.3 Premed Prostate Cancer Molecular Diagnostics Major Product Offerings
7.5.4 Premed Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Premed Key News & Latest Developments
7.6 Berryoncology
7.6.1 Berryoncology Company Summary
7.6.2 Berryoncology Business Overview
7.6.3 Berryoncology Prostate Cancer Molecular Diagnostics Major Product Offerings
7.6.4 Berryoncology Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Berryoncology Key News & Latest Developments
7.7 Gene+
7.7.1 Gene+ Company Summary
7.7.2 Gene+ Business Overview
7.7.3 Gene+ Prostate Cancer Molecular Diagnostics Major Product Offerings
7.7.4 Gene+ Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Gene+ Key News & Latest Developments
7.8 Annoroad
7.8.1 Annoroad Company Summary
7.8.2 Annoroad Business Overview
7.8.3 Annoroad Prostate Cancer Molecular Diagnostics Major Product Offerings
7.8.4 Annoroad Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Annoroad Key News & Latest Developments
7.9 Topgen
7.9.1 Topgen Company Summary
7.9.2 Topgen Business Overview
7.9.3 Topgen Prostate Cancer Molecular Diagnostics Major Product Offerings
7.9.4 Topgen Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Topgen Key News & Latest Developments
7.10 Geneis
7.10.1 Geneis Company Summary
7.10.2 Geneis Business Overview
7.10.3 Geneis Prostate Cancer Molecular Diagnostics Major Product Offerings
7.10.4 Geneis Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Geneis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
